By Staff
Friday, May 3, 2024 12:27 AM
NEW YORK—The national average for gross revenue at ECP locations decreased last week, April 22–28, when compared with the previous week at a rate of -2 index points. That places gross revenue at a level 5 index points above where it was at this point in time (Week 17) when compared with last year (2023), 11 points above the same period in 2022, 14 points above 2021, 102 points above 2020 (during COVID) and 19 points above 2019, according to Jobson’s most recent Practice Performance Tracker.
By Staff
Friday, May 3, 2024 12:24 AM
ALISO VIEJO, Calif.—
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, has announced financial results for the first quarter ended March 31, 2024. Net sales in the first quarter of 2024 increased 16 percent to $85.6 million, compared with $73.9 million in the same period in 2023. The company also raised 2024 net sales guidance to a range of $357 million to $365 million, compared with a range of $350 million to $360 million previously.
By Staff
Friday, May 3, 2024 12:21 AM
PADUA, Italy—
Safilo Group reported yesterday that the company has signed a perpetual license agreement with Authentic Brands Group (Authentic) for David Beckham Eyewear, which substitutes the previous contract expiring at the end of 2030. Under the new agreement, Safilo will continue to oversee the entire value chain, including the design process creatively led by David Beckham, through to its production and global distribution. Beckham unveiled his first Eyewear by David Beckham collection in 2020, debuting a new eyewear brand designed by Beckham in collaboration with Safilo Group, and available to buy worldwide.
By Staff
Friday, May 3, 2024 12:18 AM
BOSTON—The board of trustees at
New England College of Optometry (NECO) has announced its honorary degree recipient, two Presidential Medal awardees, and six valedictorians as part of its 130th commencement exercises to be held on May 19, 2024, at Boston’s Symphony Hall. Myopia expert and research leader Jane Gwiazda, Ph.D., is the honorary degree recipient. Marge Axelrad, editorial director emeritus of
Vision Monday and
VMAIL, and Marc Ferrara, executive consultant for Jobson Optical Group, will receive the Presidential Medal awards.
By Staff
Friday, May 3, 2024 12:15 AM
BOSTON—
20/20 Onsite, a Boston-based mobile eyecare company, is partnering with Southbridge Public Schools (SPS) and the
Health Foundation of Central Massachusetts to provide comprehensive eye exams and glasses to SPS students at no cost to their families through the “Vision for Southbridge” program. 20/20 Onsite’s licensed optometrists will visit schools throughout the spring and fall of 2024, and all students in participating schools, from preschool to high school, are eligible to receive eye exams at no cost, regardless of their insurance coverage.
By Staff
Thursday, May 2, 2024 12:30 AM
SECAUCUS, N.J.—
Safilo North America has announced the appointment of Gabriele Cusani Sodano as president and chief commercial officer, effective April 2024. Cusani brings a wealth of experience and a proven track record to succeed in this new role, which will focus on accelerating the implementation of the Group’s strategic plan in the North American market, the company stated. He joined Safilo in 2015 and has held various roles of increasing responsibility throughout his tenure, with experience that spans commercial strategy and planning, brand management, business development, sales operations and direct to consumer.
By Staff
Thursday, May 2, 2024 12:27 AM
VAUGHAN, Ontario—
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced its first-quarter 2024 financial results. The company reported that revenue grew 18 percent (20 percent on a constant currency basis) compared with the first quarter of 2023, driven by growth across all business segments. The company also raised full-year 2024 constant currency revenue growth guidance to 13 percent to 15 percent and the full-year revenue range to between $4.600 billion and $4.700 billion.
By Staff
Thursday, May 2, 2024 12:24 AM
LARGO, Fla.—More than 55 customers and industry partners recently gathered at the annual
Ocuco Innovations User Group Meeting (UGM). Held in April with the theme "Seas the Day," the event brought together optical lab professionals for three days of education and networking.
By Staff
Thursday, May 2, 2024 12:21 AM
LAKE FOREST, Calif.—
STAAR Surgical Company, developer, manufacturer and marketer of the EVO family of implantable collamer lenses (EVO ICL) for myopia, astigmatism and presbyopia, has announced that Nancy Sabin has been named chief marketing officer and Nathaniel Sisitsky has been named general counsel.
By Staff
Thursday, May 2, 2024 12:18 AM
TORONTO, Canada—
RetiSpec, Inc., an innovator in artificial intelligence-powered eye diagnostics for brain health, and
Topcon Healthcare, Inc., a provider of medical devices and software solutions, have announced that Topcon has invested in RetiSpec, and the two companies are collaborating to bring RetiSpec technology to market.
By Staff
Thursday, May 2, 2024 12:15 AM
CHARENTON-LE-PONT, FRANCE—To honor this year’s Presbyopia Awareness Month, the
World Council of Optometry (WCO), in partnership with
EssilorLuxottica, has announced the release of the global standard of care for presbyopia and the aging eye. According to the announcement, the aim of this resolution is to set a benchmark through evidence-based resources that center on the eyecare practitioner's attention toward the three pillars of mitigating, measuring and managing presbyopia.
By Staff
Wednesday, May 1, 2024 12:30 AM
CHARENTON-LE-PONT, France—
EssilorLuxottica held its annual shareholders meeting yesterday in Paris, the company announced, where shareholders approved all 34 resolutions submitted by the board of directors to the Ordinary and Extraordinary General Meeting. These included the distribution of a €3.95 dividend per share for the financial year 2023, the compensation policy applicable to the company’s executive corporate officers and the reappointment of all previous directors to the new board of directors. “On behalf of the board of directors, we would like to extend warm thanks to our shareholders for their continued support and trust," said Francesco Milleri, chairman and CEO, and Paul du Saillant, deputy CEO at EssilorLuxottica.
By Staff
Wednesday, May 1, 2024 12:27 AM
NEW YORK—Women’s influence in optical is undeniable, and today more women are playing vital roles at all levels of our industry. In retailing, wholesaling, product design, manufacturing, distribution and vision care, talented women are shaping the direction of the companies and organizations they work for, and, in many cases, lead. This is why
Vision Monday will once again be highlighting The Most Influential Women in Optical in our July-August issue, marking the 22nd year of our signature Special Report saluting women in the eyewear/eyecare industry.
By Staff
Wednesday, May 1, 2024 12:24 AM
SAN DIEGO—
Toku, Inc., a commercial medical device company specializing in imaging technology and artificial intelligence, has announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to its MyKidneyAI technology, which uses AI to analyze retinal images collected at routine eye exams to detect elevated chronic kidney disease risk in people with diabetes.
By Staff
Wednesday, May 1, 2024 12:21 AM
MIAMI—
Innovative Eyewear, Inc., developer and seller of smart eyewear, has announced that it has entered into a definitive agreement for the issuance and sale of 4,200,822 shares of its common stock at a purchase price per share of $0.244 in a registered direct offering.